Explore Stanford technologies available for licensing:

Stanford researchers have developed multivalent SIRP-alpha fusion polypeptides that selectively block the CD47–SIRP-alpha immune checkpoint with enhanced potency, enabling next-generation immunotherapies that promote immune clearance of cancer and diseased cells while minimizi

Stanford researchers have developed the Broadly Usable Multi-Pass Engineered Receptor (BUMPER) architecture, a novel protein engineering platform for assembling stable, multifunctional cell surface receptors.

Researchers in the Onori Lab have developed a state of charge (SOC) estimation technique for Lithium Iron Phosphate (LFP) batteries using machine learning.

Stanford scientists have developed the Programmable Antigen-Mediated Cellular Knock-in of T cell (PACK-IT) platform that enables rapid CAR-T cell engineering in hours rather than weeks.

Stanford researchers have developed an innovative wearable device that enhances mindfulness training by augmenting the user's real-time auditory environment.

The Stanford team has dramatically enhanced materials properties crucial for low-temperature quantum photonic and phononic applications.

Stanford researchers have developed EphrinA3 technology to strengthen epithelial barriers by increasing expression of cell-cell adhesion molecules, particularly desmoglein-1 (DSG1) and desmocollin-1 (DSC1).

Stanford researchers in the Onori Lab have developed a method for accurately estimating battery state-of-charge (SOC) using the inverse derivative of galvanostatic voltage response (dQ/dV) curve.

Stanford researchers in the Onori Lab have developed a battery management system (BMS) that uses sine-wave current pulses to accurately determine a battery's state-of-charge (SOC).

Stanford scientists have developed Plate-C, a high-throughput screening platform that captures genome-wide 3D chromatin architecture as a comprehensive cellular phenotype.

Stanford researchers have developed a novel technology called FLASH (Functional Assigning Sequence Homing) that predicts phenotypes directly from raw sequencing data, bypassing assembly and alignment, while revealing the biological features driving those predictions.

Researchers at Stanford in collaboration with researchers at NYU have identified novel epitopes on Lymphocyte activation gene-3 (LAG-3) that regulate T cell activation. Blocking those LAG-3 epitopes has potential as a novel immune checkpoint inhibitor therapy.

Stanford scientists have developed a parametrically programmable delay line that uses superconducting circuits to store and manipulate quantum information with dynamic control capabilities.

Stanford researchers have developed an innovative method for efficiently generating robust lymphatic endothelial cells (iLECs) from human induced pluripotent stem cells (hiPSCs) through transcription factor-based protocols.

Stanford researchers have identified a small set of genes that can be used to diagnose active tuberculosis (TB), distinguish active TB from latent TB or other diseases, and predict progression from latent to active TB months before conventional tests.